|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yao Z, Zhang L and Ji G: Efficacy of
polyphenolic ingredients of Chinese herbs in treating dyslipidemia
of metabolic syndromes. J Integr Med. 12:135–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Feng X, Scott A, Wang Y, Wang L, Zhao Y,
Doerner S, Satake M, Croniger CM and Wang Z: PTPRT regulates
high-fat diet-induced obesity and insulin resistance. PLoS One.
9:e1007832014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song HY, Zhang L, Pan JL, Yang LL and Ji
G: Bioactivity of five components of Chinese herbal formula
Jiangzhi granules against hepatocellular steatosis. J Integr Med.
11:262–268. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu J, Zhang H, Zheng H and Jiang Y:
Hepatic inflammation scores correlate with common carotid
intima-media thickness in rats with NAFLD induced by a high-fat
diet. BMC Vet Res. 10:1622014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khanna AK: Enhanced susceptibility of
cyclin kinase inhibitor p21 knockout mice to high fat diet induced
atherosclerosis. J Biomed Sci. 16:662009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Potter JD: Nutrition and colorectal
cancer. Cancer Causes Control. 7:127–146. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yiu HY, Whittemore AS and Shibata A:
Increasing colorectal cancer incidence rates in Japan. Int J
Cancer. 109:777–781. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu CS, Hsu HS, Li CI, Jan CI, Li TC, Lin
WY, Lin T, Chen YC, Lee CC and Lin CC: Central obesity and
atherogenic dyslipidemia in metabolic syndrome are associated with
increased risk for colorectal adenoma in a Chinese population. BMC
Gastroenterol. 10:512010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Notarnicola M, Altomare DF, Correale M,
Ruggieri E, D'Attoma B, Mastrosimini A, Guerra V and Caruso MG:
Serum lipid profile in colorectal cancer patients with and without
synchronous distant metastases. Oncology. 68:371–374. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He T, Qi F, Jia L, Wang S, Song N, Guo L,
Fu Y and Luo Y: MicroRNA-542-3p inhibits tumour angiogenesis by
targeting angiopoietin-2. J Pathol. 232:499–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hosseini H, Rajabibazl M, Ebrahimizadeh W
and Dehbidi GR: Inhibiting angiogenesis with human single-chain
variable fragment antibody targeting VEGF. Microvasc Res. 97:13–18.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang Y, Song N, Ding Y, Yuan S, Li X, Cai
H, Shi H and Luo Y: Pulmonary vascular destabilization in the
premetastatic phase facilitates lung metastasis. Cancer Res.
69:7529–7537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang H, Bhat A, Woodnutt G and Lappe R:
Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer.
10:575–585. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Augustin HG, Koh GY, Thurston G and
Alitalo K: Control of vascular morphogenesis and homeostasis
through the angiopoietin-Tie system. Nat Rev Mol Cell Biol.
10:165–177. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Carvalho MI, Pires I, Prada J, Raposo TP,
Gregório H, Lobo L and Queiroga FL: High COX-2 expression is
associated with increased angiogenesis, proliferation and tumoural
inflammatory infiltrate in canine malignant mammary tumours: A
multivariate survival study. Vet Comp Oncol. 15:619–631. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jakobsdottir G, Xu J, Molin G, Ahrné S and
Nyman M: High-fat diet reduces the formation of butyrate, but
increases succinate, inflammation, liver fat and cholesterol in
rats, while dietary fibre counteracts these effects. PLoS One.
8:e804762013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Perry B, Zhang J, Saleh T and Wang Y:
Liuwei Dihuang, a traditional Chinese herbal formula, suppresses
chronic inflammation and oxidative stress in obese rats. J Integr
Med. 12:447–454. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Zhao XW, Liu DB, Han CZ, Du LL,
Jing JX and Wang Y: Lipid levels in serum and cancerous tissues of
colorectal cancer patients. World J Gastroenterol. 20:8646–8652.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murai T: Cholesterol lowering: Role in
cancer prevention and treatment. Biol Chem. 396:1–11. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hirsch HA, Iliopoulos D, Joshi A, Zhang Y,
Jaeger SA, Bulyk M, Tsichlis PN, Liu Shirley X and Struhl K: A
transcriptional signature and common gene networks link cancer with
lipid metabolism and diverse human diseases. Cancer Cell.
17:348–361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barquilla Cano P, Pagano ES,
Jiménez-Ortega V, Fernández-Mateos P, Esquifino AI and Cardinali
DP: Melatonin normalizes clinical and biochemical parameters of
mild inflammation in diet-induced metabolic syndrome in rats. J
Pineal Res. 57:280–290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jusakul A, Yongvanit P, Loilome W, Namwat
N and Kuver R: Mechanisms of oxysterol-induced carcinogenesis.
Lipids Health Dis. 10:442011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kampschulte M, Stöckl C, Langheinrich AC,
Althöhn U, Bohle RM, Krombach GA, Stieger P, Churin Y, Kremer S,
Dierkes C, et al: Western diet in ApoE-LDLR double-deficient mouse
model of atherosclerosis leads to hepatic steatosis, fibrosis, and
tumorigenesis. Lab Invest. 94:1273–1282. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Flores MBS, Rocha GZ, Damas-Souza DM,
Osório-Costa F, Dias MM, Ropelle ER, Camargo JA, de Carvalho RB,
Carvalho HF, Saad MJA and Carvalheira JBC: RETRACTED:
Obesity-induced increase in tumor necrosis factor-α leads to
development of colon cancer in mice. Gastroenterology.
143(741–753): e42012.PubMed/NCBI
|
|
26
|
Al Rifai M, Silverman MG, Nasir K, Budoff
MJ, Blankstein R, Szklo M, Katz R, Blumenthal RS and Blaha MJ: The
association of nonalcoholic fatty liver disease, obesity, and
metabolic syndrome, with systemic inflammation and subclinical
atherosclerosis: The multi-ethnic study of atherosclerosis (MESA).
Atherosclerosis. 239:629–633. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Landskron G, De la Fuente M, Thuwajit P,
Thuwajit C and Hermoso MA: Chronic inflammation and cytokines in
the tumor microenvironment. J Immunol Res. 2014:1491852014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hefler LA, Grimm C, Ackermann S, Malur S,
Radjabi-Rahat AR, Leodolter S, Beckmann MW, Zeillinger R, Koelbl H
and Tempfer CB: An interleukin-6 gene promoter polymorphism
influences the biological phenotype of ovarian cancer. Cancer Res.
63:3066–3068. 2003.PubMed/NCBI
|
|
29
|
Middleton K, Jones J, Lwin Z and Coward
JI: Interleukin-6: An angiogenic target in solid tumours. Crit Rev
Oncol Hematol. 89:129–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eldesoky A, Shouma A, Mosaad Y and
Elhawary A: Clinical relevance of serum vascular endothelial growth
factor and interleukin-6 in patients with colorectal cancer. Saudi
J Gastroenterol. 17:170–173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Danese S, Sans M, de la Motte C, Graziani
C, West G, Phillips MH, Pola R, Rutella S, Willis J, Gasbarrini A
and Fiocchi C: Angiogenesis as a novel component of inflammatory
bowel disease pathogenesis. Gastroenterology. 130:2060–2073. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kulbe H, Thompson R, Wilson JL, Robinson
S, Hagemann T, Fatah R, Gould D, Ayhan A and Balkwill F: The
inflammatory cytokine tumor necrosis factor-alpha generates an
autocrine tumor-promoting network in epithelial ovarian cancer
cells. Cancer Res. 67:585–592. 2007. View Article : Google Scholar : PubMed/NCBI
|
